Explore the Regulatory Expectations for Rare vs. Non-Rare Diseases

Time: 2:00 pm
day: Conference Day One


  • Discuss how cell and gene therapy products, disease characteristics, patient population, and therapeutic goals influence the regulatory expectations
  • Understand how regulatory agency’s approach for rare vs non-rare diseases
  • Explore strategies to effectively demonstrate safety and efficacy in rare vs non-rare diseas